Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 10.23 M | $94.11 M | 0.00% | 16.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 5.38 M | $49.51 M | 5.86% | 8.60% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 5.25 M | $48.30 M | 0.00% | 8.39% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 4.67 M | $42.97 M | 8.92% | 7.47% |
| BLACKROCK, INC. | 11/12/2025 | 3.71 M | $34.10 M | -15.35% | 5.93% |
| VANGUARD GROUP INC | 11/07/2025 | 3.00 M | $27.60 M | -4.67% | 4.80% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 2.43 M | $22.37 M | -47.00% | 3.89% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.45 M | $13.34 M | 8.39% | 2.32% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.45 M | $13.33 M | 23.18% | 2.32% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.30 M | $11.95 M | -5.34% | 2.08% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 1.29 M | $11.86 M | 200.85% | 2.06% |
| STATE STREET CORP | 11/14/2025 | 1.06 M | $9.78 M | -12.74% | 1.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.00 M | $9.24 M | -15.85% | 1.61% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.00 M | $9.21 M | 23,633.67% | 1.60% |
| CITADEL ADVISORS LLC | 11/14/2025 | 854.56 K | $7.86 M | 414.07% | 1.37% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 678.41 K | $6.24 M | 379.86% | 1.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 586.35 K | $5.39 M | -48.72% | 0.94% |
| NORTHERN TRUST CORP | 11/14/2025 | 568.32 K | $5.23 M | -7.07% | 0.91% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 540.64 K | $4.97 M | -4.04% | 0.86% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 384.14 K | $3.53 M | 12.14% | 0.61% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 366.30 K | $3.37 M | 79.21% | 0.59% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 341.61 K | $3.14 M | 540.33% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 333.48 K | $3.07 M | -14.00% | 0.53% |
| JANE STREET GROUP, LLC | 11/14/2025 | 321.52 K | $2.96 M | 1,744.95% | 0.51% |
| UBS GROUP AG | 11/13/2025 | 301.16 K | $2.77 M | 122.74% | 0.48% |
| BESSEMER GROUP INC | 11/05/2025 | 286.99 K | $2.64 M | 0.00% | 0.46% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 285.33 K | $2.63 M | 2.18% | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 248.20 K | $2.28 M | 216.18% | 0.40% |
| MORGAN STANLEY | 11/14/2025 | 243.84 K | $2.24 M | -22.45% | 0.39% |
| BRAIDWELL LP | 11/14/2025 | 219.49 K | $2.02 M | 100.00% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 179.36 K | $1.65 M | 41.89% | 0.29% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 152.24 K | $1.40 M | 15.03% | 0.24% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 150.87 K | $1.39 M | 42.74% | 0.24% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 147.21 K | $1.35 M | 220.10% | 0.24% |
| ABRDN PLC | 11/07/2025 | 137.96 K | $1.27 M | 135.04% | 0.22% |
| FIDUCIARY TRUST CO | 11/14/2025 | 136.56 K | $1.26 M | 0.00% | 0.22% |
| J. GOLDMAN & CO LP | 11/14/2025 | 135.00 K | $1.24 M | 100.00% | 0.22% |
| HRT FINANCIAL LP | 11/14/2025 | 124.92 K | $1.15 M | 100.00% | 0.20% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 124.67 K | $1.15 M | 100.00% | 0.20% |
| INVESCO LTD. | 11/13/2025 | 123.87 K | $1.14 M | -73.66% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 119.16 K | $1.10 M | -13.02% | 0.19% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 116.07 K | $1.07 M | 256.44% | 0.19% |
| NUVEEN, LLC | 11/12/2025 | 112.20 K | $1.03 M | -10.04% | 0.18% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11/14/2025 | 111.58 K | $1.03 M | 0.00% | 0.18% |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 10/28/2025 | 102.47 K | $942.72 K | 100.00% | 0.16% |
| EXOME ASSET MANAGEMENT LLC | 11/14/2025 | 98.80 K | $908.95 K | -77.80% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 95.40 K | $877.68 K | -2.25% | 0.15% |
| BARCLAYS PLC | 11/12/2025 | 89.62 K | $824.47 K | -20.03% | 0.14% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 83.43 K | $768.00 K | 0.00% | 0.13% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 83.23 K | $765.75 K | 13.78% | 0.13% |
Fulcrum Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 160 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.23 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.38 M
TCG Crossover Management, LLC: 5.25 M
Nantahala Capital Management, LLC: 4.67 M
BlackRock, Inc.: 3.71 M
VANGUARD GROUP INC: 3 M
86.08% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 59.43 M shares in the last 24 months. This purchase volume represents approximately $547.98 M in transactions.